These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25374237)

  • 21. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of
    Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
    Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The -31 G/C promoter gene polymorphism of surviving in Turkish colorectal cancers patients.
    Budak M; Bozkurt C; Cetin SE; Tuncel H
    Ceylon Med J; 2018 Sep; 63(3):119-123. PubMed ID: 30415515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
    Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
    BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer.
    Han CH; Wei Q; Lu KK; Liu Z; Mills GB; Wang LE
    Int J Clin Exp Med; 2009 Oct; 2(4):289-99. PubMed ID: 20057973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.
    Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R
    Mol Biol Rep; 2013 Aug; 40(8):4819-26. PubMed ID: 23645041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.
    Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW
    DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
    Rahimi Z; Yari K; Rahimi Z
    Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
    Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the survivin gene and the risk of lung cancer.
    Jang JS; Kim KM; Kang KH; Choi JE; Lee WK; Kim CH; Kang YM; Kam S; Kim IS; Jun JE; Jung TH; Park JY
    Lung Cancer; 2008 Apr; 60(1):31-39. PubMed ID: 17961802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of survivin gene polymorphism with endometrial cancer.
    Zahedi P; Aminimoghaddam S; Sayahpour FA; Haghpanah V; Amiri P; Fereidoni F; Mahrampour E; Larijani B; Tavakkoly-Bazzaz J; Amoli MM
    Int J Gynecol Cancer; 2012 Jan; 22(1):35-7. PubMed ID: 21897272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
    Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
    Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
    Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
    Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of survivin polymorphisms with tumor susceptibility: a meta-analysis.
    Zhu Y; Li Y; Zhu S; Tang R; Liu Y; Li J
    PLoS One; 2013; 8(9):e74778. PubMed ID: 24098667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the antiapoptotic protein survivin in colon cancer.
    Hernandez JM; Farma JM; Coppola D; Hakam A; Fulp WJ; Chen DT; Siegel EM; Yeatman TJ; Shibata D
    Clin Colorectal Cancer; 2011 Sep; 10(3):188-93. PubMed ID: 21855041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer.
    Mojtahedi Z; Mohmedi M; Rahimifar S; Erfani N; Hosseini SV; Ghaderi A
    Gene; 2012 Oct; 508(2):229-32. PubMed ID: 22892379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of H-ras polymorphisms and susceptibility to sporadic colon cancer.
    Catela Ivkovic T; Loncar B; Spaventi R; Kapitanovic S
    Int J Oncol; 2009 Nov; 35(5):1169-73. PubMed ID: 19787272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.